Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4441 Gastric neuroendocrine neoplasms in younger patients: A retrospective single-centre study

Introduction: Gastric neuroendocrine neoplasms (gNENs) are rare neoplasms arising from stomach enterochromaffin-like (ECL) cells. Type I gNENs are the most common type, typically indolent and arising in the context of chronic atrophic gastritis (CAG). While type I gNENs are generally diagnosed in pts over 50, their occurrence in younger pts raises concern about the onset of CAG-related complications at an earlier age, potentially affecting tumour growth and clinical outcomes. Young-oriented studies on type I gNETs are still lacking in literature.

Conference:

Presenting Author:

Authors: Romano E, Rinzivillo M, Marasco M, Dell' Unto E, Esposito G,

Keywords: Gastric neuroendocrine neoplasm, Young adults, Chronic Atrophic Gastritis,

#4315 The indolent nature of type 1 gastric neuroendocrine tumours under 1cm: Insights from a dual-centre study

Introduction: Current guidelines primarily recommend endoscopic surveillance for type 1 gastric neuroendocrine tumours (g-NETs) measuring ≤10mm, though these guidelines are largely based on expert consensus rather than strong evidence.

Conference:

Presenting Author:

Authors: Dell' Unto E, Riding G, Rimondi A, Rinzivillo M, Esposito G,

Keywords: Gastric Neuroendocrine Tumour, Carcinoid, Endoscopic Surveillance,

#3686 Clinical and morphogenetic features of renal neuroendocrine tumors

Introduction: Renal neuroendocrine tumors (RenNETs) are extremely rare.

Conference:

Presenting Author: Kasajima A

Authors: Kasajima A, Pfarr N, von Werder A, Schwamborn K, Esposito I,

Keywords: Renal NET, WHO classification, Histology, immunohistochemistry, NGS,

#3508 Liver transplantation for metastatic neuroendocrine tumors: Time to extend criteria?

Introduction: Liver transplant (LT) might be considered in patients with liver-only neuroendocrine metastases (NELM), but controversy continues surrounding patient selection.

Conference:

Presenting Author: Ross R

Authors: Rossi R, Maspero M, Coppa J, Sposito C, Bhoori S,

Keywords: neuroendocrine tumor, neuroendocrine liver metastasis, liver transplant,

#3506 Different patterns of recurrence after liver resection and transplantation for metastatic neuroendocrine tumors. Single center ecperience

Introduction: Liver metastases (NELM) occur in nearly half of NET pts, 80%are unresectable, and affect their prognosis. Surgery remains the most effective option; curative liver resection (LR) and liver transplantation (LT) offer the best long-term outcomes with difficult to show outcome differences due to the long course of the disease. The risk of tumor recurrence is considerable after both approaches.

Conference:

Presenting Author: Coppa J

Authors: Coppa J, Rossi R, Bongini M, Maspero M, Sposito C,

Keywords: liver metastasis, surgery, liver transplantation, recurrence,